Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Neoplasia (New York, N.Y.)|June 22, 2005
Acute tumor response to ZD6126 assessed by intrinsic susceptibility magnetic resonance imagingSimon P Robinson, Tammy L Kalber, Franklyn A Howe, et al.NMR in Biomedicine|July 22, 2014
Multicentre evaluation of the INTERPRET decision support system 2.0 for brain tumour classificationMargarida Julià-Sapé, Carles Majós, Àngels Camins, et al.Endocrine-Related Cancer|November 6, 2013
Anosmin-1 contributes to brain tumor malignancy through integrin signal pathwaysCatherine T Choy, Haseong Kim, Ji-Young Lee, et al.NMR in Biomedicine|April 27, 2007
MRS quality assessment in a multicentre study on MRS-based classification of brain tumoursMarinette van der Graaf, Margarida Julià-Sapé, Franklyn A Howe, et al.Journal of Magnetic Resonance Imaging : JMRI|March 26, 2003
Tumor vascular architecture and function evaluated by non-invasive susceptibility MRI methods and immunohistochemistrySimon P Robinson, Paul F J W Rijken, Franklyn A Howe, et al.BMC Neuroscience|January 21, 2010
Tri-partite complex for axonal transport drug delivery achieves pharmacological effectAaron G Filler, Garth T Whiteside, Mark Bacon, et al.International Journal of Radiation Oncology, Biology, Physics|July 16, 2013
Evaluation and immunohistochemical qualification of carbogen-induced ΔR₂ as a noninvasive imaging biomarker of improved tumor oxygenationLauren C J Baker, Jessica K R Boult, Yann Jamin, et al.Trials|May 24, 2017
Perfusion by Arterial Spin labelling following Single dose Tadalafil In Small vessel disease (PASTIS): study protocol for a randomised controlled trialMathilde M H Pauls, Natasha Clarke, Sarah Trippier, et al.Journal of Biomedical Informatics|March 8, 2011
Incremental Gaussian Discriminant Analysis based on Graybill and Deal weighted combination of estimators for brain tumour diagnosisSalvador Tortajada, Elies Fuster-Garcia, Javier Vicente, et al.NMR in Biomedicine|February 2, 2024
Characterisation of paediatric brain tumours by their MRS metabolite profilesSimrandip K Gill, Heather E L Rose, Martin Wilson, et al.Pageof 8